Cargando…
Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer
MicroRNA-191 (miR-191) has been identified as being upregulated in several types of cancers, and plays the role of oncogene. The expression of miR-191 has been found to be upregulated in prostate cancer tissues as well as cell lines. In this study, we analyzed the correlation of miR-191 expression w...
Autores principales: | Liu, Jing-bo, Yan, Yong-ji, Shi, Jing, Wu, Ya-bing, Li, Yan-feng, Dai, Lin-feng, Ma, Xue-tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709308/ https://www.ncbi.nlm.nih.gov/pubmed/31335671 http://dx.doi.org/10.1097/MD.0000000000016193 |
Ejemplares similares
-
Upregulation of PD-L1 predicts poor prognosis and is associated with
miR-191-5p dysregulation in colon adenocarcinoma
por: Chen, Xiao-Yu, et al.
Publicado: (2018) -
Can Mean Platelet Volume Serve as a Marker for Prostatitis?
por: Karaman, Hatice, et al.
Publicado: (2013) -
MicroRNA-98 can serve as a diagnostic marker for congenital heart disease-associated pulmonary artery hypertension
por: Zhang, Yao-Zhong, et al.
Publicado: (2020) -
Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020) -
MicroRNA‐191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR‐191/KLF6 axis
por: Tian, Fang, et al.
Publicado: (2019)